{"id":"n_6t33o5ekrjwptgyxl7ka","seq":9689389,"kind":"article","title":"Every GLP-1 Drug Label, Including Ozempic and Zepbound, Must Warn of Rare Sudden Vision Loss in One Eye","url":"https://www.medicaldaily.com/fda-glp-1-drugs-naion-vision-loss-warning-481080","summary":"The FDA is requiring all GLP-1 drug labels to warn of a potential increased risk of rare eye condition NAION, while advising patients not to stop treatment without medical guidance.","published":"2026-11-11T02:25:43Z","seen":"2026-11-11T02:53:00Z","lang":"en","country":"US","source":{"id":"kite-medicaldaily-com-05fda3","name":"medicaldaily.com","domain":"medicaldaily.com"},"via":"kite-medicaldaily-com-05fda3","topics":["medicine"],"mentions":2,"story":"st_ip5lwh6i62lc5aqavsnq","category":"health","category_p":0.67,"sentiment":"neutral","tone":-0.38,"political":0.05}